Business Wire

SoftBank Corp. and Intelsat Launch Landmark Collaboration to Create Ubiquitous Network

Share

SoftBank Corp. (“SoftBank”) and Intelsat signed a groundbreaking collaboration agreement that will lead to the launch of a single “Ubiquitous Network” enabling customers to stay connected everywhere they go. SoftBank and Intelsat will jointly lead research and development of seamless 5G connections between terrestrial mobile networks and satellite communications networks.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240916589802/en/

In a society where everyone and everything is increasingly dependent on staying connected, convenient, and always-on, telecommunications are essential. However, despite the coming realization of autonomous mobility with automobiles, ships, drones and other vehicles, many areas are still without ground-based mobile network coverage and require separate devices and accounts to connect to non-terrestrial networks.

Through the new collaboration, SoftBank and Intelsat plan to jointly develop a hybrid communication solution that allows users to stay connected via available networks, whether terrestrial or satellite, anywhere in the world with the convenience of one device and one account. The solution will build on the same standard architectures, interfaces and processes that enable roaming of devices between terrestrial cellular networks today and will help make the commercial adoption of mobility solutions based on new 3GPP 5G standards for non-terrestrial networks a reality much sooner.

One of the key goals of the collaboration is to develop a universal device that will always stay connected regardless of where in the world it goes. For example, a future connected vehicle equipped with such a device will be able to seamlessly switch to a non-terrestrial satellite communication network when outside of terrestrial mobile network coverage. The targeted solution is expected to have wide commercial applicability, including in land mobile, maritime, and disaster response and recovery.

Design, development, field testing and commercialization of new hybrid network products between Intelsat and SoftBank will be conducted in phases, aligned with the development of the new 3GPP 5G non-terrestrial network standards. The resulting hybrid solutions will allow for existing satellite terminals to be used in the near term and newer 5G-based terminals as they become available.

“Intelsat and SoftBank share a pioneering vision of Ubiquitous Networking and seamless interoperability between satellite and terrestrial networks,” said Bruno Fromont, Intelsat Chief Technology Officer. “Until now, the challenge was aligning standards that allowed the two different networks to connect. With recent progress on 5G-based standardization of non-terrestrial networks led by Intelsat at 3GPP and this strategic collaboration with SoftBank, we are ideally positioned to accelerate the design and practical implementation of commercial hybrid services that will allow devices to freely roam between satellite and terrestrial networks.”

Hideyuki Tsukuda, Executive Vice President and CTO of SoftBank said, "By using technology that switches between terrestrial mobile networks and satellite communication networks through roaming, we can integrate the two previously separate networks and utilize satellite communication as an extension of mobile communication. Through this joint research and development, SoftBank and Intelsat will aim to build a Ubiquitous Network where people and things around the world can be connected to communication anytime, anywhere."

About Intelsat

Intelsat’s global team of professionals is focused on providing seamless and secure, satellite-based communications to government, NGO and commercial customers through the company’s next-generation worldwide network and managed services. Bridging the digital divide by operating one of the world’s largest and most advanced satellite fleet and connectivity infrastructures, Intelsat enables people and their tools to speak over oceans, see across continents and listen through the skies to communicate, cooperate and coexist. Since its founding six decades ago, the company has been synonymous with satellite-industry “firsts” in service to its customers and the planet. Leaning on a legacy of innovation and focusing on addressing a new generation of challenges Intelsat team members now have their sights on the “next firsts” in space as they disrupt the field and lead in the digital transformation of the industry.

About SoftBank Corp.

Guided by the SoftBank Group’s corporate philosophy, “Information Revolution – Happiness for everyone,” SoftBank Corp. (TOKYO: 9434) operates telecommunications and IT businesses in Japan and globally. In the fiscal year ended March 2024, SoftBank Corp. registered 6,084.0 billion yen of revenue, 876.1 billion yen of operating income and 489.1 billion yen of net income. SoftBank Corp. has 40 million mobile subscribers in Japan, and through its group companies, 63 million smartphone payment (PayPay) users, 85 million online media (Yahoo! JAPAN) users and 97 million communication app (LINE) users (as of May 9, 2024). Building on its strong business foundation, SoftBank Corp. is expanding into non-telecom fields in line with its “Beyond Carrier” growth strategy while further growing its telecom business by harnessing the power of 5G/6G, IoT, Digital Twin and Non-Terrestrial Network (NTN) solutions, including High Altitude Platform Station (HAPS)-based stratospheric telecommunications. While constructing AI data centers and developing homegrown LLMs specialized for the Japanese language with 1 trillion parameters, SoftBank is applying AI to enhance radio access network performance (AI-RAN) with the aim of becoming a provider of next-generation social infrastructure. In recognition of its ESG initiatives, SoftBank Corp. was selected for inclusion in the Dow Jones Sustainability World Index (DJSI World) for 2022 and 2023, achieving the highest score in Japan and registering as the only company in the country to be selected for the Telecommunication Services industry group in 2023. To learn more, please visit https://www.softbank.jp/en/.

Follow Us on Social Media:
Twitter/X: https://twitter.com/INTELSAT
LinkedIn: https://www.linkedin.com/company/intelsat
Instagram: https://www.instagram.com/intelsat/?hl=en
YouTube: https://www.youtube.com/user/intelsatmedia

View source version on businesswire.com: https://www.businesswire.com/news/home/20240916589802/en/

Contacts

Melissa Longo - melissa.longo@intelsat.com; +1 240-308-1881

Melissa Longo - melissa.longo@intelsat.com; +1 240-308-1881

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release

Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem

Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release

Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played

Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release

At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will

Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release

Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.

MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release

MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye